In this piece, we will take a look at the top five best stocks to buy under $20 according to Jeremy Green's Redmile Group.
Keep Reading →
May 3 - Hedge Funds, News - Comments
In this article, we will discuss the top 10 biotech stocks to buy according to Jeremy Green's Redmile Group.
Keep Reading →
February 17 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
February 7 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
December 10 - Hedge Funds, News - Comments
In this article, we discuss the 5 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Keep Reading →
November 30 - Hedge Funds, News - Comments
In this article, we discuss the best small-cap stocks to buy.
Keep Reading →
October 29 - Hedge Funds, News - Comments
In this article, we will take a look at 15 biotech and pharmaceutical stocks to buy according to Palo Alto Investors.
Keep Reading →
October 23 - Hedge Funds, News - Comments
In this article, we will discuss the 10 best biotech stocks to buy according to Joseph Edelman’s Perceptive Advisors.
Keep Reading →
October 15 - Hedge Funds, News - Comments
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Keep Reading →
October 12 - Hedge Funds, News - Comments
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Keep Reading →
July 6 - Hedge Funds, News - Comments
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” first quarter 2021 investor letter – a copy of which can be ...
Keep Reading →
May 5 - Hedge Fund Investor Letters, News - Comments
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
April 8 - Hedge Funds, News - Comments
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
December 21 - Hedge Funds, News - Comments
Below are the 5 best biotech stocks to invest in according to the billionaire biotech hedge fund manager Joe Edelman.
Keep Reading →
December 19 - News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Keep Reading →
September 15 - Hedge Funds, News - Comments
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
July 12 - Hedge Funds, News - Comments
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
June 8 - Hedge Funds, News - Comments
We hate to say this but, we told you so.
Keep Reading →
March 28 - Hedge Funds, News - Comments
2018's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about...
Keep Reading →
January 10 - Hedge Funds, News - Comments
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Keep Reading →
December 5 - Hedge Funds, News - Comments
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Keep Reading →
October 24 - Hedge Funds, News - Comments
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could...
Keep Reading →
June 19 - Hedge Funds, News - Comments
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed...
Keep Reading →
December 10 - Hedge Funds, News - Comments
Warren Buffett’s Berkshire Hathaway Inc. is hopping on the fintech bandwagon.
Keep Reading →
October 29 - Hedge Funds, Insider Trading - Comments
Billionaire Ken Griffin hired two veteran money managers from Louis Bacon’s hedge fund as he seeks to build a rival macro business.
Keep Reading →
October 2 - Hedge Funds, Insider Trading - Comments
Famed investor Bill Miller is still a believer in Facebook. "This too will pass," he said in an email to CNBC's Scott Wapner.
Keep Reading →
March 21 - Hedge Funds, Insider Trading - Comments
President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S.
Keep Reading →
March 2 - News, Stock Analysis - Comments
Amicus Therapeutics, Inc.
Keep Reading →
December 22 - News, Stock Analysis - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD) just announced a convertible senior notes offering, and the company is trending down on he back of the news.
Keep Reading →
December 15 - News, Stock Analysis - Comments
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Keep Reading →
December 7 - Hedge Funds, News - Comments
It’s time to take a look at those stocks that really moved over the last twenty-four hours or so in biotech, and there are plenty to go at.
Keep Reading →
November 29 - Market Movers, News, Stock Analysis - Comments
Despite of all the negative sentiment looming around them, hedge funds had a pretty solid run for much of this year, generating positive returns for seven or eight consecutive...
Keep Reading →
November 15 - Hedge Funds, News - Comments
While wider markets turn there focus to the US elections, the biotech space is alive and well, and after a tough end to last week, a number of companies have enjoyed gains throughout...
Keep Reading →
November 8 - Market Movers, News - Comments
Joseph Edelman's Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being invested in healthcare stocks.
Keep Reading →
November 8 - Hedge Funds, News - Comments
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk of their market capitalization...
Keep Reading →
October 8 - Hedge Funds, News - Comments
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience in wealth management...
Keep Reading →
June 3 - Hedge Fund Analysis, Hedge Funds, News - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD)'s lead drug candidate is migalastat, which targets Fabry disease.
Keep Reading →
May 21 - News - Comments
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China's slowdown.
Keep Reading →
April 12 - Market Movers, News - Comments
Oil went back to tumbling on Friday, with crude oil losing more than 3.5%. On the other hand, markets returned to positive territory, with major U.S.
Keep Reading →
April 1 - Market Movers, News - Comments
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech...
Keep Reading →
February 27 - Hedge Funds, News - Comments
Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector.
Keep Reading →
February 26 - Hedge Funds, News - Comments
Over the past few months the healthcare sector has undergone a roller coaster of a ride, especially in August and September when many investors got wary of the sector being overvalued...
Keep Reading →
December 20 - Hedge Funds, News - Comments
Given elite hedge funds have filed their latest 13F's, we have an opportunity to analyze what hedge funds like and what they don't like.
Keep Reading →
December 11 - Hedge Funds, News - Comments
The third-quarter stock market correction has turned out to resemble the situation observed during the Asian financial crisis of 1997.
Keep Reading →
November 25 - Hedge Funds, News - Comments
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc.
Keep Reading →
November 2 - Market Movers, News - Comments
It’s a good Monday for investors of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV), Amicus Therapeutics, Inc. (NASDAQ:FOLD), and Oasis Petroleum Inc.
Keep Reading →
October 5 - Market Movers, News - Comments
Three stocks trending significantly low today before afternoon were Amicus Therapeutics, Inc.
Keep Reading →
October 2 - Market Movers, News - Comments
Biotech Guru Joseph Edelman's Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks.
Keep Reading →
June 25 - Hedge Funds, News - Comments
Ken Griffin's Citadel Investment Group has increased its stakes in Tuesday Morning Corporation (NASDAQ:TUES), Swift Transportation Co (NYSE:SWFT), and Amicus Therapeutics, Inc...
Keep Reading →
April 28 - Hedge Funds, News - Comments
Jeremy Green's Redmile Group has also reduced its stake in Amicus Therapeutics, Inc.
Keep Reading →
October 9 - Hedge Funds, News - Comments